Blocking Nucleotides for Somatic Mutation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting somatic mutations, particularly in cancer diagnostics, face challenges in sensitivity and specificity due to the presence of wild-type material and low copies of mutated templates, leading to false negatives and false positives.
Innovation Solution
The use of specially modified blocking nucleotides that allow for the sensitive detection of low copies of variant sequences while reducing signals from non-variant sequences, employing a blocking oligonucleotide with hydrophobic nucleotides and a set of primers capable of amplifying the target nucleic acid sequence, thereby distinguishing between variant and reference sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PCR methods are used to detect somatic mutations, then the detection process is simple and fast, but the sensitivity is insufficient leading to false negatives due to low copies of mutated templates in wild-type background
Solution Approach 1:
The patent introduces blocking nucleotides as intermediary molecules that specifically bind to wild-type sequences during PCR amplification. These blocking nucleotides prevent amplification of wild-type DNA while allowing amplification of mutated sequences, thereby enhancing detection sensitivity without requiring complex sample preparation or analysis procedures
Solution Approach 2:
The patent modifies the chemical parameters of the PCR reaction by incorporating blocking nucleotides with specific binding affinities and concentrations. By adjusting the ratio of blocking nucleotides to primers and optimizing their concentration, the method achieves high sensitivity for detecting rare mutations while maintaining a relatively simple PCR-based workflow
2Measurement precision
If conventional PCR methods are used to detect somatic mutations, then the procedure is straightforward, but the specificity is insufficient leading to false positives
Solution Approach 1:
The blocking nucleotides act as specific intermediaries that selectively inhibit amplification of wild-type sequences. By designing blocking nucleotides with high specificity for wild-type sequences, the method achieves better detection specificity while maintaining a relatively simple PCR-based workflow without requiring complex validation procedures
Solution Approach 2:
Instead of trying to directly detect and identify mutated sequences among wild-type background, the patent inverts the approach by specifically blocking and preventing amplification of wild-type sequences. This allows the rare mutated sequences to be detected more specifically without the interference of abundant wild-type templates
3Reliability
If blocking nucleotides are used to improve detection sensitivity, then false negatives are reduced, but the detection method becomes more complex
Solution Approach 1:
The blocking nucleotides serve as intermediary molecules that can be incorporated into existing PCR workflows with minimal modification. By using commercially available blocking nucleotide reagents and standard PCR equipment, the method achieves high reliability without requiring complex custom-built detection systems or specialized instrumentation
Solution Approach 2:
The blocking nucleotide approach can be applied to detect various types of somatic mutations across different genes and cancer types using a universal PCR-based platform. By designing specific blocking nucleotides for different mutation hotspots, the method achieves broad applicability and high reliability without requiring completely different detection systems for each application
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the detection of rare variants, improving the accuracy of cancer diagnostics and personalized treatment strategies by reducing false positives and negatives, and is applicable beyond cancer diagnostics to other applications like non-invasive prenatal testing.
Implementation Method 1
employing a blocking oligonucleotide with hydrophobic nucleotides and a set of primers capable of amplifying the target nucleic acid sequence, thereby distinguishing between variant and reference sequences
Implementation Method 2
a blocking oligonucleotide with hydrophobic nucleotides
Implementation Method 3
performing a polymerase chain reaction in the presence of said sample, said blocking oligonucleotide; said set of primers and PCR reagents
Data Source
AI summary
Provided herein are specially modified blocking nucleotides allowing for the sensitive detection of low copies of variant sequences, while significantly reducing signals from non-variant sequences that are similar but not identical to the variant sequence. These nucleotides can be used to detect rare variants in a sample mixture, as described in the present methods.